ReviewTranslational lung cancer research2021
Current and future biomarkers for outcomes with immunotherapy in non-small cell lung cancer.
Boris Duchemann et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
25 papers cite it
this papercites it